Saul Factor Named President of Smith Drug Company
SPARTANBURG, S.C. – J M Smith Corporation has announced that its leading innovative technology solutions will now be under the leadership of Kevin Welch. Former QS/1 President, Saul Factor, RPh will lead the wholesale distribution business units Smith Drug Company and Burlington Drug Company. “The decision to align our technology offerings under one leader was made to further enhance our customer focus. Kevin is a highly respected technology leader with a passion for moving pharmacy forward. Under his guidance, QS/1 and Integra customers can expect a commitment to technology excellence and responsiveness,” said Alan Turfe, CEO and Chairman of the Board, J M Smith Corporation. “During his time as president of QS/1, Saul led with transparency and a contagious drive to advance customer centricity and business excellence. I am looking forward to seeing what both Kevin and Saul can accomplish for our customers in their new roles” Welch was named Chief Technology Officer for J M Smith Corporation in 2017. In the CTO role, he oversees the development of innovative technology within the J M Smith Corporation, streamlining the process of bringing pharmacy solutions to market. Welch became part of J M Smith Corporation with the acquisition of Integra, which he founded in 1997. Welch holds degrees in Mathematics, Computer Science, Operations Research and Engineering Management from Stanford University and has served in senior positions at Genentech, Symantec and Microsoft. During his career he has designed and developed many industry leading software applications and systems.
“I am excited by this tremendous opportunity,” said Welch. “Aligning all our technology offerings benefits the customers in all of the markets we serve. We will continue to have dedicated teams for each of these markets – long term care, community pharmacy and governmental, while sharing best practices across all of them.”
ABOUT J M SMITH CORPORATION
J M Smith Corporation, headquartered in Spartanburg, is South Carolina’s third-largest privately owned company. Today, the corporation is focused in the areas of health care and technology, and operates through multiple business units, including Smith Drug Company, QS/1, Integral Solutions Group, RxMedic Systems, Integra LTC Solutions and Burlington Drug Company. For more information, visit www.JMSmithCorp.com.